Mark Kagan

Analysis of 1,3-butadiene and other selected gas-phase components in cigarette mainstream and sidestream smoke by gas chromatography-mass selective detection

Klaus D. Brunnemann, Mark Kagan, Jonathan E. Cox et al. · Carcinogenesis · 1990 · 159 citations

Natural Sciences, Chemistry, Toxicology +10

Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers

Peter G. Foiles, Shobha A. Akerkar, Steven G. Carmella et al. · Chemical Research in Toxicology · 1991 · 122 citations

Pharmacy, Biochemistry, Toxicology +12

Validation of biomarkers in humans exposed to benzene: Urine metabolites

Qingshan Qu, Assieh A. Melikian, Guilan Li et al. · American Journal of Industrial Medicine · 2000 · 120 citations

Pharmacy, Toxicology, Environmental Toxicology +16

Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and nonsmokers.

Steven G. Carmella, Shashi S. Kagan, Mark Kagan et al. · PubMed · 1990 · 100 citations

Pharmacy, Biochemistry, Toxicology +14

Determination of the urinary benzene metabolites S-phenylmercapturic acid and trans,trans-muconic acid by liquid chromatography-tandem mass spectrometry

Assieh A. Melikian, Ray O’Connor, Agasanur K. Prahalad et al. · Carcinogenesis · 1999 · 100 citations · Full text

Pharmacy, Toxicology, Analytical Toxicology +15